Use of microorganisms for the prevention and treatment of intestinal diseases
Abstract
The invention relates to acetylcholine-producing microorganisms for use in the prevention and/or treatment of intestinal diseases, and/or reduction of risks of intestinal diseases, and/or improvement of intestinal health as well as promoting healthy gut flora. The acetylcholine-producing microorganisms may be provided as a pharmaceutical dosage form or as additive to functional food or food supplemental products. Also encompassed is a method for the production of acetylcholine by use of Lactobacilli . Further the invention refers to microbially produced acetylcholine for use in the treatment and/or prevention of intestinal diseases.
Claims
exact text as granted — not AI-modified1 . An acetylcholine-producing microorganism for medical use in the prevention and/or treatment of intestinal diseases, and/or reduction of risk of intestinal diseases.
2 . The acetylcholine-producing microorganism for use according to claim 1 , for maintaining and/or promoting a healthy gut flora and/or reducing the toxic effects of the digestive process and/or stimulating the digestive system and/or improving intestinal control.
3 . The acetylcholine-producing microorganism for use according to claim 1 , wherein the intestinal disease is a functional intestinal disorder and/or a disorder associated with the secretions of the intestinal wall controlled by the enteric nervous system, in particular functional constipation, functional diarrhea and/or irritable bowel syndrome (IBS), more particular constipation predominant IBS, alternating IBS or diarrhea predominant IBS.
4 . The acetylcholine-producing microorganism for use according to claim 1 , wherein the intestinal disease is an inflammatory bowel disease, in particular ulcerative colitis and/or Crohn's disease.
5 . The acetylcholine-producing microorganism for use according to claim 1 , wherein the microorganism produces ≧30 mg/kg acetylcholine under suitable culture conditions.
6 . The acetylcholine-producing microorganism for use according to claim 1 , wherein the microorganism is a bacterium.
7 . The acetylcholine-producing microorganism for use according to claim 1 , wherein the microorganism is a Lactobacillus strain, in particular a Lactobacillus sanfranciscensis strain, a Lactobacillus rossiae strain, a Lactobacillus brevis strain or a Lactobacillus plantarum strain, more particularly strains DSM 23090 or DSM 23093.
8 . The acetylcholine-producing microorganism for use according to claim 1 , wherein the Lactobacillus is selected from any one of strains DSM 26024, DSM 23090, DSM 23091, DSM 23200, DSM 23092, DSM 23093, DSM 23201, DSM 23174 and DSM 23121 or a strain cultivated therefrom.
9 . The acetylcholine-producing microorganism for use according to claim 1 in a pharmaceutical dosage form, in a functional food or in a functional beverage.
10 . The acteylcholine-producing microorganism for use according to claim 9 , wherein the functional food is sourdough bread.
11 . The acetylcholine-producing microorganism for use according to claim 9 , further comprising at least one additional bacterium for maintaining and/or restoring a favorable gut flora.
12 . The acetylcholine-producing microorganism for use according to claim 9 , further comprising at least one additional medicament for the treatment of intestinal diseases.
13 . A method for the production of acetylcholine by use of lactobacilli , particularly by the use of lactobacilli selected from Lactobacillus sanfranciscensis and Lactobacillus rossiae strains.
14 . A method for the treatment and/or prevention of intestinal diseases, in a patient in need of such, comprising orally administering microbially produced acetylcholine to said patient.
15 . Non-medical use of an acetylcholine-producing microorganism for maintenance and/or improvement of intestinal health.
16 . (canceled)Join the waitlist — get patent alerts
Track US2015374763A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.